Cell Isolation Market

Cell Isolation Market / Cell Separation Market by Product (Consumables, Instruments), Cell Type (Human Cells, Animal Cells), Cell Source (Bone Marrow, Adipose Tissues), Technique (Centrifugation-based), Application, End User (Pharma) - Global Forecast to 2028

Report Code: BT 2757 May, 2023, by marketsandmarkets.com

The global cell isolation market in terms of revenue was estimated to be worth $4.4 billion in 2023 and is poised to reach $8.2 billion by 2028, growing at a CAGR of 13.4% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

Various elements such as increasing government funding for cell-based research and the increasing number of patients suffering from cancer & infectious diseases, and the technological advancements, are driving the market growth.

Attractive Opportunities in the Cell Isolation Market

Cell Isolation/Cell Separation Market

To know about the assumptions considered for the study, Request for Free Sample Report

Cell Isolation/Cell Separation Market

Cell Isolation Market Dynamics

DRIVER: Increased government funding for cell-based research

For the development of cell-based treatments, cell isolation is the critical step. Cell-based research is important in several applications, hence various government bodies across the world have funded for such research activities. For instance, in May 2021, the National Institutes of Health (NIH) announced the award of USD 30.0 million in grants to support research aimed at developing new tools and technologies for studying cells. The funding was awarded to multiple institutions across the United States, including Harvard University, the University of California San Francisco, and the University of Texas Southwestern Medical Center. Moreover, under the Government’s Medical Research Future Fund (MRFF), the Stem Cell Therapies Mission is investing USD 150.0 million over 10 years. This investment will be utilized in stem cell research, which will eventually improve healthcare outcomes. This type of funding will boost cell-based research globally, leading to an increase in the demand for cell isolation products and ultimately boosting the market.

RESTRAINT: Safety & ethical issues to hamper the market growth

The process of embryonic stem cells isolation involves the destruction of the embryo from which the cells are derived. This raises ethical concerns about the destruction of human life, as the embryo is considered by some to be a potential human being. Embryonic stem cells have the ability to form teratomas, which are tumors that contain cells from all three germ layers. If embryonic stem cells are transplanted into a patient without proper screening, they can potentially form tumors and cause harm. Thus, these factors can potentially hamper the market growth to a certain extent.

OPPORTUNITY: Growth opportunities in emerging markets

Emerging markets such as China, India, and Brazil are experiencing rapid growth in their biopharmaceutical industries. This is driven by factors such as increasing healthcare spending, a growing aging population, and a rise in chronic diseases. The increasing demand for biopharmaceuticals in these markets is driving the need for cell isolation technologies to develop and manufacture these products. Moreover, emerging markets are investing in the development and adoption of advanced technologies such as microfluidics, magnetic cell separation, and flow cytometry. This is improving the efficiency and accuracy of cell isolation processes, and making these technologies more accessible and affordable in these markets. Also, there is a growing trend of research and development activities in emerging markets. Governments and private institutions in these regions are investing in research to develop new therapies and treatments for chronic diseases. Cell isolation is a critical step in the development of these therapies, and thus, the growth of research activities in these markets is driving the growth of the market.

CHALLENGE: Difficulties to develop cell therapies

The development of cell therapies is a major challenge for the market, as it requires the isolation and manipulation of specific cell types that can be used for therapeutic purposes. Different cell types have different characteristics and functions, which makes it difficult to isolate and purify specific cell populations. This can result in a heterogeneous population of cells, which can reduce the effectiveness of the therapy. Isolated cells need to be viable and functional in order to be used in therapies. However, the isolation process can damage cells, which can reduce their viability and functionality. The quality of isolated cells needs to be carefully controlled in order to ensure their safety and effectiveness. This can be challenging, as cells can be affected by a range of environmental factors, such as temperature, pH, and oxygen levels. Overall, these obstacles to the development of cell therapies are significant challenges for the market.

Consumables segment dominated the cell isolation market in 2022.

Based on product, the market is broadly segmented into consumables and instruments. In 2022, consumables accounted for the dominant share of the market. This segment's large share can be attributed to factors such as the repetitive use of consumables in the cell isolation. Furthermore, the increasing number of regulatory approvals of new consumables is likely to upsurge the growth of the segment.

The biomolecule isolation segment of cell isolation market is expected to grow at the highest CAGR during the forecast period.

Based on application, the market is segmented into biomolecule isolation, stem cell research, cancer research, in vitro diagnostics, and tissue regeneration & regenerative medicine, and other applications. The biomolecule isolation segment is expected to register the highest CAGR during the forecast period. Launch of advanced and new products is one of the factors driving the market growth.

Cell Isolation/Cell Separation Market by Region

To know about the assumptions considered for the study, download the pdf brochure

North America dominated cell isolation market in 2022.

Geographically, the market is divided geographically into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America held the greatest market share for cell isolation in 2022, followed by Europe and the Asia-Pacific region. A number of variables, including technical development, expansion of the biotechnology and pharmaceutical industries, and rising incidence of infectious and chronic diseases, account for the major share of the American market.

Key players in the cell isolation market are Danaher Corporation (US), Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (US), Becton, Dickinson and Company (US), Terumo Corporation (Japan), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), Corning Incorporated (US), F. Hoffmann-La Roche Ltd. (Switzerland), Miltenyi Biotec (Germany), STEMCELL Technologies (Canada), Alfa Laval (Sweden), Sartorius AG (Germany), Akadeum Life Sciences (US), Bio-Techne (US), PerkinElmer Inc. (US), Invent Biotechnologies, Inc. (US), Takara Bio, Inc. (Japan), MiCareo Inc. (US), Proteintech Group, Inc. (US), QIAGEN (Germany), Lonza (Switzerland), Promega Corporation (US), PluriSelect Life Science UG (Haftungsbeschränkt) & Co. KG (Germany), and MagBio Genomics (US).

Cell Isolation Market Report Scope:

Report Metric 

Details 

Market Revenue in 2023

$4.4 billion

Projected Revenue by 2028

$8.2 billion

Revenue Rate

Poised to grow at a CAGR of 13.4%

Market Driver

Increased government funding for cell-based research

Market Opportunity

Growth opportunities in emerging markets

This report categorizes the cell isolation market to forecast revenue and analyze trends in each of the following submarkets:

By Product

  • Consumables
    • Reagents, Kits, Media & Sera
    • Beads
      • Magnetic Beads
      • Fluroscent Beads
    • Disposables
  • Instruments
    • Centrifuges
    • Cell Sorters
    • Magnetic-activated Cell Seperator Systems
    • Filtration Systems

By Cell Type

  • Human Cells
    • Differntiated Cells
    • Stem Cells
  • Animal Cells

By Cell Source

  • Bone Marrow
  • Adipose Tissues
  • Cord Blood/ Embryonic Stem Cells
  • Other Cell Sources

By Technique

  • Centrifugation-based Cell Isolation
  • Surface Marker-based Cell Isolation
  • Filtration-based Cell Isolation
  • Cell Isolation Market, by Application
  • Biomolecule Isolation
  • Cancer Research
  • Stem Cell Research
  • Tissue Regeneration & Regenerative Medicine
  • In-vitro Diagnostics
  • Other Applications

By End User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Hospitals & Diagnostic Laboratories
  • Other End Users

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Recent Developments

  • In October 2022, Thermo Fisher Scientific, Inc. launched DynaCellect, a next-generation cell isolation, cell activation, cell depletion instrument. It also launched the Dynabeads magnetic beads removal instrument to optimize the cell therapy manufacturing process.
  • In June 2022, Terumo BCT and GenCure collaborated to advance cell and gene therapy manufacturing solutions.
  • In May 2022, Terumo BCT inaugurated its second manufacturing facility in Colorado.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 30)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE 
          FIGURE 1 CELL ISOLATION MARKET SEGMENTATION
           1.3.1 YEARS CONSIDERED
    1.4 CURRENCY 
    1.5 LIMITATIONS 
    1.6 STAKEHOLDERS 
    1.7 SUMMARY OF CHANGES 
           1.7.1 RECESSION IMPACT
 
2 RESEARCH METHODOLOGY (Page No. - 36)
    2.1 RESEARCH APPROACH 
          FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY RESEARCH
           2.1.2 PRIMARY RESEARCH
                    FIGURE 3 CELL ISOLATION MARKET: PRIMARY RESPONDENTS
    2.2 MARKET ESTIMATION METHODOLOGY 
          FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2022
          FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022
          FIGURE 6 MARKET SIZE ESTIMATION: APPROACH 2 (TOP-DOWN-BASED ESTIMATION), 2022
           2.2.1 INSIGHTS FROM PRIMARY EXPERTS
                    FIGURE 7 INSIGHTS ON MARKET FROM PRIMARY EXPERTS
    2.3 MARKET GROWTH RATE PROJECTIONS 
          FIGURE 8 MARKET: CAGR PROJECTIONS, 2023–2028
          FIGURE 9 MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
    2.4 DATA TRIANGULATION 
          FIGURE 10 DATA TRIANGULATION METHODOLOGY
    2.5 RESEARCH ASSUMPTIONS 
    2.6 RISK ANALYSIS 
    2.7 RECESSION IMPACT 
          TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)
 
3 EXECUTIVE SUMMARY (Page No. - 48)
    FIGURE 11 CELL ISOLATION MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    FIGURE 12 MARKET, BY CELL TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 13 MARKET, BY CELL SOURCE, 2023 VS. 2028 (USD MILLION)
    FIGURE 14 MARKET, BY TECHNIQUE, 2023 VS. 2028 (USD MILLION)
    FIGURE 15 MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    FIGURE 16 MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    FIGURE 17 GEOGRAPHICAL SNAPSHOT OF MARKET
 
4 PREMIUM INSIGHTS (Page No. - 53)
    4.1 MARKET OVERVIEW 
          FIGURE 18 INCREASING FUNDING FOR CELL-BASED RESEARCH TO DRIVE GROWTH
    4.2 NORTH AMERICA: MARKET, BY PRODUCT AND COUNTRY (2022) 
          FIGURE 19 CONSUMABLES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
    4.3 MARKET SHARE, BY APPLICATION, 2023 VS. 2028 
          FIGURE 20 BIOMOLECULE ISOLATION SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2028
    4.4 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 56)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 22 CELL ISOLATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
          TABLE 2 MARKET: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 Increasing government funding for cell-based research
                                TABLE 3 NIH FUNDING FOR CELL-BASED RESEARCH, 2019–2022 (USD MILLION)
                    5.2.1.2 Increasing number of patients suffering from cancer and infectious diseases
                                TABLE 4 INCIDENCE OF CANCER, BY REGION, 2020
                                TABLE 5 IMPORTANT STATISTICS ON INFECTIOUS DISEASES
                    5.2.1.3 Technological advancements
                    5.2.1.4 Growing focus on personalized medicine
                                TABLE 6 FDA APPROVAL RATE FOR PERSONALIZED MEDICINES, 2015–2021
           5.2.2 RESTRAINTS
                    5.2.2.1 Ethical & safety issues related to embryonic stem cell isolation
                    5.2.2.2 High cost of cell-based research
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growth opportunities in emerging markets
           5.2.4 CHALLENGES
                    5.2.4.1 Obstacles to developing cell therapies
    5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
          FIGURE 23 REVENUE SHIFT AND NEW REVENUE POCKETS
    5.4 PRICING ANALYSIS 
          TABLE 7 PRICE OF KEY CELL ISOLATION PRODUCTS OF KEY COMPANIES (2022)
    5.5 VALUE CHAIN ANALYSIS 
          FIGURE 24 MARKET: VALUE CHAIN ANALYSIS
    5.6 ECOSYSTEM ANALYSIS 
          TABLE 8 MARKET ECOSYSTEM
    5.7 REGULATORY ANALYSIS 
    5.8 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 9 CELL ISOLATION/ CELL SEPARATION MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.8.1 THREAT FROM NEW ENTRANTS
           5.8.2 THREAT FROM SUBSTITUTES
           5.8.3 BARGAINING POWER OF SUPPLIERS
           5.8.4 BARGAINING POWER OF BUYERS
           5.8.5 DEGREE OF COMPETITION
    5.9 KEY CONFERENCES & EVENTS IN 2023–2024 
          TABLE 10 MARKET: DETAILED LIST OF CONFERENCES & EVENTS
    5.10 TECHNOLOGY ANALYSIS 
           5.10.1 MICROFLUIDICS
           5.10.2 MAGNETIC CELL ISOLATION
           5.10.3 FLUORESCENCE-ACTIVATED CELL SORTING (FACS)
           5.10.4 ACOUSTIC CELL ISOLATION
           5.10.5 ACOUSTO-FLUIDIC CELL ISOLATION
    5.11 KEY STAKEHOLDERS & BUYING CRITERIA 
           FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CELL ISOLATION PRODUCTS
           FIGURE 26 KEY BUYING CRITERIA FOR CELL ISOLATION PRODUCTS
    5.12 TRADE ANALYSIS 
           TABLE 11 EXPORT DATA (TOP 10 COUNTRIES)
           TABLE 12 IMPORT DATA (TOP 10 COUNTRIES)
    5.13 PATENT ANALYSIS 
           FIGURE 27 PATENT APPLICATIONS RELATED TO CELL ISOLATION, JANUARY 2012–MARCH 2023
           TABLE 13 LIST OF PATENTS IN MARKET
 
6 CELL ISOLATION MARKET, BY PRODUCT (Page No. - 73)
    6.1 INTRODUCTION 
          TABLE 14 MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
    6.2 CONSUMABLES 
          TABLE 15 CELL ISOLATION CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 16 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 17 EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 18 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 19 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 20 CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
           6.2.1 REAGENTS, KITS, MEDIA, AND SERA
                    6.2.1.1 Disposable nature of reagents and assay kits to drive consistent usage and frequent purchases
                                TABLE 21 CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 22 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 23 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 24 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 25 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR REAGENTS, KITS, MEDIA, AND SERA, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.2 BEADS
                    TABLE 26 CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 27 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 28 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 29 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 30 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 31 CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION)
                    6.2.2.1 Magnetic beads
                               6.2.2.1.1 Growing demand for magnetic beads in T-cell and stem cell isolation to drive growth
                                              TABLE 32 CELL ISOLATION CONSUMABLES MARKET FOR MAGNETIC BEADS, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 33 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 34 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 35 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 36 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR MAGNETIC BEADS, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.2.2.2 Fluorescent beads
                               6.2.2.2.1 Advantages of fluorescent beads to boost adoption
                                              TABLE 37 CELL ISOLATION CONSUMABLES MARKET FOR FLUORESCENT BEADS, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 38 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 39 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 40 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 41 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR FLUORESCENT BEADS, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.3 DISPOSABLES
                    6.2.3.1 Growing government investments in research to boost growth
                                TABLE 42 CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 43 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 44 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 45 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 46 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR DISPOSABLES, BY COUNTRY, 2021–2028 (USD MILLION)
    6.3 INSTRUMENTS 
          TABLE 47 CELL ISOLATION INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 48 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 49 EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 50 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 51 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 52 CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
           6.3.1 CENTRIFUGES
                    6.3.1.1 Growing use of centrifuges in pharma-biotech industry to boost market
                                TABLE 53 CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 54 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 55 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 56 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 57 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CENTRIFUGES, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.2 CELL SORTERS
                    6.3.2.1 Launch of innovative and cost-effective cell sorters to support market
                                TABLE 58 CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 59 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 60 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 61 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 62 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR CELL SORTERS, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.3 MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS
                    6.3.3.1 Growing focus on personalized medicine to drive segmental growth
                                TABLE 63 CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 64 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 65 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 66 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 67 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.4 FILTRATION SYSTEMS
                    6.3.4.1 Increasing research activities in cell biology to boost market
                                TABLE 68 CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 69 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 70 EUROPE: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 71 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 72 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET FOR FILTRATION SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)
 
7 CELL ISOLATION MARKET, BY CELL TYPE (Page No. - 98)
    7.1 INTRODUCTION 
          TABLE 73 MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
    7.2 HUMAN CELLS 
          TABLE 74 MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 75 MARKET FOR HUMAN CELLS, BY REGION, 2021–2028 (USD MILLION)
          TABLE 76 NORTH AMERICA: MARKET FOR HUMAN CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 77 EUROPE: MARKET FOR HUMAN CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 78 ASIA PACIFIC: MARKET FOR HUMAN CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 79 LATIN AMERICA: MARKET FOR HUMAN CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
           7.2.1 DIFFERENTIATED CELLS
                    7.2.1.1 Growing investments by market players to develop new and innovative products to support growth
                                TABLE 80 MARKET FOR DIFFERENTIATED CELLS, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 81 NORTH AMERICA: MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 82 EUROPE: MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 83 ASIA PACIFIC: MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 84 LATIN AMERICA: MARKET FOR DIFFERENTIATED CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
           7.2.2 STEM CELLS
                    7.2.2.1 Rising government initiatives focused on supporting stem cell research to drive market
                                TABLE 85 MARKET FOR STEM CELLS, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 86 NORTH AMERICA: MARKET FOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 87 EUROPE: MARKET FOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 88 ASIA PACIFIC: MARKET FOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 89 LATIN AMERICA: MARKET FOR STEM CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
    7.3 ANIMAL CELLS 
           7.3.1 INCREASING INVESTMENTS IN BIOPHARMACEUTICAL R&D FOR VACCINE AND DRUG DEVELOPMENT TO BOOST MARKET
                    TABLE 90 MARKET FOR ANIMAL CELLS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 91 NORTH AMERICA: MARKET FOR ANIMAL CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 92 EUROPE: MARKET FOR ANIMAL CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 93 ASIA PACIFIC: MARKET FOR ANIMAL CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 94 LATIN AMERICA: MARKET FOR ANIMAL CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
 
8 CELL ISOLATION MARKET, BY CELL SOURCE (Page No. - 109)
    8.1 INTRODUCTION 
          TABLE 95 MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION)
    8.2 BONE MARROW 
           8.2.1 GROWING NUMBER OF COMMERCIALIZED BONE MARROW-DERIVED STEM CELLS TO DRIVE MARKET
                    TABLE 96 MARKET FOR BONE MARROW-DERIVED CELLS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 97 NORTH AMERICA: MARKET FOR BONE MARROW-DERIVED CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 98 EUROPE: MARKET FOR BONE MARROW-DERIVED CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 99 ASIA PACIFIC: MARKET FOR BONE MARROW-DERIVED CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 100 LATIN AMERICA: MARKET FOR BONE MARROW-DERIVED CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
    8.3 ADIPOSE TISSUE 
           8.3.1 ABILITY OF ADIPOSE STEM/STROMAL CELLS TO GENERATE VARIETY OF OTHER CELL TYPES TO DRIVE DEMAND
                    TABLE 101 MARKET FOR ADIPOSE TISSUE-DERIVED CELLS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 102 NORTH AMERICA: MARKET FOR ADIPOSE TISSUE-DERIVED CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 103 EUROPE: MARKET FOR ADIPOSE TISSUE-DERIVED CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 104 ASIA PACIFIC: MARKET FOR ADIPOSE TISSUE-DERIVED CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 105 LATIN AMERICA: MARKET FOR ADIPOSE TISSUE-DERIVED CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
    8.4 CORD BLOOD/EMBRYONIC STEM CELLS 
           8.4.1 HIGH THERAPEUTIC POTENCY OF CORD BLOOD/EMBRYONIC STEM CELLS TO SUPPORT MARKET
                    TABLE 106 MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 107 NORTH AMERICA: MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 108 EUROPE: MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 109 ASIA PACIFIC: MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 110 LATIN AMERICA: MARKET FOR CORD BLOOD/EMBRYONIC CELLS, BY COUNTRY, 2021–2028 (USD MILLION)
    8.5 OTHER CELL SOURCES 
          TABLE 111 MARKET FOR OTHER CELL SOURCES, BY REGION, 2021–2028 (USD MILLION)
          TABLE 112 NORTH AMERICA: MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 113 EUROPE: MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 114 ASIA PACIFIC: MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 115 LATIN AMERICA: MARKET FOR OTHER CELL SOURCES, BY COUNTRY, 2021–2028 (USD MILLION)
 
9 CELL ISOLATION MARKET, BY TECHNIQUE (Page No. - 119)
    9.1 INTRODUCTION 
          TABLE 116 MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
    9.2 CENTRIFUGATION-BASED CELL ISOLATION 
           9.2.1 COST-EFFECTIVENESS OF TECHNIQUE IN BOTH SMALL-SCALE AND LARGE-SCALE OPERATIONS TO DRIVE MARKET
                    TABLE 117 MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 118 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 119 EUROPE: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 120 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 121 LATIN AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    9.3 SURFACE MARKER-BASED CELL ISOLATION 
           9.3.1 WIDE USAGE IN BIOPHARMACEUTICAL AND BIOTECH INDUSTRIES TO SUPPORT GROWTH
                    TABLE 122 MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 123 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 124 EUROPE: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 125 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 126 LATIN AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    9.4 FILTRATION-BASED CELL ISOLATION 
           9.4.1 LOW COST OF FILTRATION TECHNIQUE TO BOOST ADOPTION
                    TABLE 127 MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 128 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 129 EUROPE: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 130 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 131 LATIN AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
 
10 CELL ISOLATION MARKET, BY APPLICATION (Page No. - 127)
     10.1 INTRODUCTION 
             TABLE 132 MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
     10.2 BIOMOLECULE ISOLATION 
             10.2.1 BIOMOLECULE ISOLATION SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
                        TABLE 133 MARKET FOR BIOMOLECULE ISOLATION APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 134 NORTH AMERICA: MARKET FOR BIOMOLECULE ISOLATION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 135 EUROPE: MARKET FOR BIOMOLECULE ISOLATION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 136 ASIA PACIFIC: MARKET FOR BIOMOLECULE ISOLATION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 137 LATIN AMERICA: MARKET FOR BIOMOLECULE ISOLATION APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
     10.3 CANCER RESEARCH 
             10.3.1 HIGH DISEASE INCIDENCE TO FUEL DEMAND FOR ADVANCED TREATMENTS
                        TABLE 138 MARKET FOR CANCER RESEARCH APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 139 NORTH AMERICA: MARKET FOR CANCER RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 140 EUROPE: MARKET FOR CANCER RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 141 ASIA PACIFIC: MARKET FOR CANCER RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 142 LATIN AMERICA: MARKET FOR CANCER RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
     10.4 STEM CELL RESEARCH 
             10.4.1 INCREASING FUNDING IN STEM CELL RESEARCH TO SUPPORT MARKET GROWTH
                        TABLE 143 MARKET FOR STEM CELL RESEARCH APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 144 NORTH AMERICA: MARKET FOR STEM CELL RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 145 EUROPE: MARKET FOR STEM CELL RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 146 ASIA PACIFIC: MARKET FOR STEM CELL RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 147 LATIN AMERICA: MARKET FOR STEM CELL RESEARCH APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
     10.5 TISSUE REGENERATION & REGENERATIVE MEDICINE 
             10.5.1 GROWING REGENERATIVE MEDICINE INITIATIVES TO SUPPORT MARKET
                        TABLE 148 MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 149 NORTH AMERICA: MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 150 EUROPE: MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 151 ASIA PACIFIC: MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 152 LATIN AMERICA: MARKET FOR TISSUE REGENERATION & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
     10.6 IN VITRO DIAGNOSTICS 
             10.6.1 RISING DISEASE INCIDENCE TO DRIVE DEMAND FOR INNOVATIVE THERAPIES AND DIAGNOSTICS
                        TABLE 153 MARKET FOR IN VITRO DIAGNOSTIC APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 154 NORTH AMERICA: MARKET FOR IN VITRO DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 155 EUROPE: MARKET FOR IN VITRO DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 156 ASIA PACIFIC: MARKET FOR IN VITRO DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 157 LATIN AMERICA: MARKET FOR IN VITRO DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
     10.7 OTHER APPLICATIONS 
             TABLE 158 MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
             TABLE 159 NORTH AMERICA: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 160 EUROPE: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 161 ASIA PACIFIC: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 162 LATIN AMERICA: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
 
11 CELL ISOLATION MARKET, BY END USER (Page No. - 142)
     11.1 INTRODUCTION 
             TABLE 163 MARKET, BY END USER, 2021–2028 (USD MILLION)
     11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 
             11.2.1 FAVORABLE R&D INVESTMENTS TO BOOST MARKET GROWTH
                        TABLE 164 MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 165 NORTH AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 166 EUROPE: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 167 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 168 LATIN AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
     11.3 ACADEMIC & RESEARCH INSTITUTES 
             11.3.1 RISING FUNDING FOR CELL-BASED RESEARCH TO DRIVE MARKET GROWTH
                        TABLE 169 MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 170 NORTH AMERICA: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 171 EUROPE: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 172 ASIA PACIFIC: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 173 LATIN AMERICA: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
     11.4 HOSPITALS & DIAGNOSTIC LABORATORIES 
             11.4.1 INCREASING NUMBER OF HOSPITALS IN EMERGING COUNTRIES TO CONTRIBUTE TO MARKET GROWTH
                        TABLE 174 MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 175 NORTH AMERICA: MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 176 EUROPE: MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 177 ASIA PACIFIC: MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 178 LATIN AMERICA: MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)
     11.5 OTHER END USERS 
             TABLE 179 MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
             TABLE 180 NORTH AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 181 EUROPE: MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 182 ASIA PACIFIC: MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 183 LATIN AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
 
12 CELL ISOLATION MARKET, BY REGION (Page No. - 152)
     12.1 INTRODUCTION 
             TABLE 184 MARKET, BY REGION, 2021–2028 (USD MILLION)
     12.2 NORTH AMERICA 
             FIGURE 28 NORTH AMERICA: CELL ISOLATION MARKET SNAPSHOT
             TABLE 185 NORTH AMERICA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
             TABLE 186 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 187 NORTH AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 188 NORTH AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 189 NORTH AMERICA: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
             TABLE 190 NORTH AMERICA: MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 191 NORTH AMERICA: MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION)
             TABLE 192 NORTH AMERICA: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
             TABLE 193 NORTH AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 194 NORTH AMERICA: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.2.1 US
                        12.2.1.1 US to dominate North American cell isolation market during forecast period
                                      TABLE 195 US: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 196 US: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 197 US: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 198 US: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 199 US: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
                                      TABLE 200 US: MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 201 US: MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION)
                                      TABLE 202 US: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                                      TABLE 203 US: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 204 US: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.2.2 CANADA
                        12.2.2.1 Increasing funding for research in regenerative medicine to support market growth in Canada
                                      TABLE 205 CANADA: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 206 CANADA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 207 CANADA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 208 CANADA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 209 CANADA: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
                                      TABLE 210 CANADA: MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 211 CANADA: MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION)
                                      TABLE 212 CANADA: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                                      TABLE 213 CANADA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 214 CANADA: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.2.3 NORTH AMERICA: RECESSION IMPACT
     12.3 EUROPE 
             TABLE 215 EUROPE: CELL ISOLATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 216 EUROPE: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
             TABLE 217 EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 218 EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 219 EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 220 EUROPE: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
             TABLE 221 EUROPE: MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 222 EUROPE: MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION)
             TABLE 223 EUROPE: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
             TABLE 224 EUROPE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 225 EUROPE: MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.3.1 GERMANY
                        12.3.1.1 Germany to be fastest-growing market for cell isolation in Europe
                                      TABLE 226 GERMANY: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 227 GERMANY: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 228 GERMANY: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 229 GERMANY: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 230 GERMANY: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
                                      TABLE 231 GERMANY: MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 232 GERMANY: MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION)
                                      TABLE 233 GERMANY: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                                      TABLE 234 GERMANY: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 235 GERMANY: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.3.2 UK
                        12.3.2.1 Government investments in stem cell research to drive market for cell isolation in UK
                                      TABLE 236 UK: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 237 UK: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 238 UK: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 239 UK: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 240 UK: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
                                      TABLE 241 UK: MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 242 UK: MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION)
                                      TABLE 243 UK: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                                      TABLE 244 UK: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 245 UK: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.3.3 FRANCE
                        12.3.3.1 Increasing prevalence of various chronic and infectious diseases to drive market growth
                                      TABLE 246 FRANCE: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 247 FRANCE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 248 FRANCE: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 249 FRANCE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 250 FRANCE: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
                                      TABLE 251 FRANCE: MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 252 FRANCE: MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION)
                                      TABLE 253 FRANCE: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                                      TABLE 254 FRANCE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 255 FRANCE: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.3.4 ITALY
                        12.3.4.1 Increasing number of cell biology seminars and conferences to fuel adoption of cell isolation products
                                      TABLE 256 ITALY: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 257 ITALY: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 258 ITALY: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 259 ITALY: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 260 ITALY: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
                                      TABLE 261 ITALY: MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 262 ITALY: MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION)
                                      TABLE 263 ITALY: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                                      TABLE 264 ITALY: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 265 ITALY: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.3.5 SPAIN
                        12.3.5.1 Increasing funding from private and public organizations to aid growth
                                      TABLE 266 SPAIN: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 267 SPAIN: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 268 SPAIN: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 269 SPAIN: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 270 SPAIN: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
                                      TABLE 271 SPAIN: MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 272 SPAIN: MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION)
                                      TABLE 273 SPAIN: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                                      TABLE 274 SPAIN: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 275 SPAIN: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.3.6 REST OF EUROPE
                        TABLE 276 REST OF EUROPE: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 277 REST OF EUROPE: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 278 REST OF EUROPE: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 279 REST OF EUROPE: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 280 REST OF EUROPE: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
                        TABLE 281 REST OF EUROPE: MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 282 REST OF EUROPE: MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION)
                        TABLE 283 REST OF EUROPE: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                        TABLE 284 REST OF EUROPE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 285 REST OF EUROPE: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.3.7 EUROPE: RECESSION IMPACT
     12.4 ASIA PACIFIC 
             FIGURE 29 ASIA PACIFIC: CELL ISOLATION MARKET SNAPSHOT
             TABLE 286 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 287 ASIA PACIFIC: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
             TABLE 288 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 289 ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 290 ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 291 ASIA PACIFIC: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
             TABLE 292 ASIA PACIFIC: MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 293 ASIA PACIFIC: MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION)
             TABLE 294 ASIA PACIFIC: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
             TABLE 295 ASIA PACIFIC: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 296 ASIA PACIFIC: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.4.1 CHINA
                        12.4.1.1 Growing cell therapy-based research in China to boost market
                                      TABLE 297 CHINA: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 298 CHINA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 299 CHINA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 300 CHINA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 301 CHINA: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
                                      TABLE 302 CHINA: MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 303 CHINA: MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION)
                                      TABLE 304 CHINA: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                                      TABLE 305 CHINA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 306 CHINA: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.4.2 JAPAN
                        12.4.2.1 Increasing geriatric population and subsequent rise in prevalence of chronic diseases to drive market
                                      TABLE 307 JAPAN: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 308 JAPAN: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 309 JAPAN: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 310 JAPAN: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 311 JAPAN: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
                                      TABLE 312 JAPAN: MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 313 JAPAN: MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION)
                                      TABLE 314 JAPAN: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                                      TABLE 315 JAPAN: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 316 JAPAN: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.4.3 INDIA
                        12.4.3.1 Rising incidence of chronic and infectious diseases to drive demand for cell isolation products
                                      TABLE 317 INDIA: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 318 INDIA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 319 INDIA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 320 INDIA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 321 INDIA: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
                                      TABLE 322 INDIA: MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 323 INDIA: MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION)
                                      TABLE 324 INDIA: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                                      TABLE 325 INDIA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 326 INDIA: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.4.4 AUSTRALIA
                        12.4.4.1 Rising stem cell research to drive demand for cell isolation products
                                      TABLE 327 AUSTRALIA: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 328 AUSTRALIA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 329 AUSTRALIA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 330 AUSTRALIA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 331 AUSTRALIA: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
                                      TABLE 332 AUSTRALIA: MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 333 AUSTRALIA: MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION)
                                      TABLE 334 AUSTRALIA: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                                      TABLE 335 AUSTRALIA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 336 AUSTRALIA: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.4.5 REST OF ASIA PACIFIC
                        TABLE 337 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 338 REST OF ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 339 REST OF ASIA PACIFIC: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 340 REST OF ASIA PACIFIC: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 341 REST OF ASIA PACIFIC: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
                        TABLE 342 REST OF ASIA PACIFIC: MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 343 REST OF ASIA PACIFIC: MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION)
                        TABLE 344 REST OF ASIA PACIFIC: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                        TABLE 345 REST OF ASIA PACIFIC: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 346 REST OF ASIA PACIFIC: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.4.6 ASIA PACIFIC: RECESSION IMPACT
     12.5 LATIN AMERICA 
             TABLE 347 LATIN AMERICA: CELL ISOLATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 348 LATIN AMERICA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
             TABLE 349 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 350 LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 351 LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 352 LATIN AMERICA: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
             TABLE 353 LATIN AMERICA: MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION)
             TABLE 354 LATIN AMERICA: MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION)
             TABLE 355 LATIN AMERICA: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
             TABLE 356 LATIN AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
             TABLE 357 LATIN AMERICA: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.5.1 BRAZIL
                        12.5.1.1 Expansion of leading market players in country to drive market growth
                                      TABLE 358 BRAZIL: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 359 BRAZIL: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 360 BRAZIL: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 361 BRAZIL: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 362 BRAZIL: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
                                      TABLE 363 BRAZIL: MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 364 BRAZIL: MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION)
                                      TABLE 365 BRAZIL: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                                      TABLE 366 BRAZIL: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 367 BRAZIL: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.5.2 REST OF LATIN AMERICA
                        TABLE 368 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 369 REST OF LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 370 REST OF LATIN AMERICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 371 REST OF LATIN AMERICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 372 REST OF LATIN AMERICA: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
                        TABLE 373 REST OF LATIN AMERICA: MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 374 REST OF LATIN AMERICA: MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION)
                        TABLE 375 REST OF LATIN AMERICA: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                        TABLE 376 REST OF LATIN AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 377 REST OF LATIN AMERICA: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.5.3 LATIN AMERICA: RECESSION IMPACT
     12.6 MIDDLE EAST & AFRICA 
             12.6.1 GROWING PHARMACEUTICAL INDUSTRY IN MEA TO DRIVE MARKET GROWTH
                        TABLE 378 MIDDLE EAST & AFRICA: CELL ISOLATION MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 379 MIDDLE EAST & AFRICA: CELL ISOLATION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 380 MIDDLE EAST & AFRICA: CELL ISOLATION CONSUMABLES MARKET FOR BEADS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 381 MIDDLE EAST & AFRICA: CELL ISOLATION INSTRUMENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 382 MIDDLE EAST & AFRICA: MARKET, BY CELL TYPE, 2021–2028 (USD MILLION)
                        TABLE 383 MIDDLE EAST & AFRICA: MARKET FOR HUMAN CELLS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 384 MIDDLE EAST & AFRICA: MARKET, BY CELL SOURCE, 2021–2028 (USD MILLION)
                        TABLE 385 MIDDLE EAST & AFRICA: MARKET, BY TECHNIQUE, 2021–2028 (USD MILLION)
                        TABLE 386 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 387 MIDDLE EAST & AFRICA: CELL ISOLATION MARKET, BY END USER, 2021–2028 (USD MILLION)
             12.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
 
13 COMPETITIVE LANDSCAPE (Page No. - 234)
     13.1 INTRODUCTION 
     13.2 STRATEGIES ADOPTED BY KEY PLAYERS 
             FIGURE 30 CELL ISOLATION MARKET: STRATEGIES ADOPTED
     13.3 MARKET SHARE ANALYSIS 
             FIGURE 31 MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER (2022)
             TABLE 388 MARKET: DEGREE OF COMPETITION
     13.4 REVENUE ANALYSIS 
             FIGURE 32 MARKET: REVENUE ANALYSIS, BY KEY PLAYER (2020–2022)
     13.5 COMPANY EVALUATION MATRIX 
             FIGURE 33 MARKET: COMPANY EVALUATION MATRIX, 2022
             13.5.1 STARS
             13.5.2 EMERGING LEADERS
             13.5.3 PERVASIVE PLAYERS
             13.5.4 PARTICIPANTS
     13.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 
             13.6.1 OVERALL COMPANY FOOTPRINT (25 COMPANIES)
                        TABLE 389 END-USER, PRODUCT, AND REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
             13.6.2 END-USER FOOTPRINT OF COMPANIES (25 COMPANIES)
                        TABLE 390 END-USER FOOTPRINT ANALYSIS OF KEY PLAYERS
             13.6.3 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
                        TABLE 391 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
             13.6.4 PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES)
                        TABLE 392 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS
     13.7 COMPANY EVALUATION MATRIX FOR START-UPS/SMES 
             FIGURE 34 MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
             13.7.1 PROGRESSIVE COMPANIES
             13.7.2 STARTING BLOCKS
             13.7.3 RESPONSIVE COMPANIES
             13.7.4 DYNAMIC COMPANIES
             13.7.5 COMPETITIVE BENCHMARKING OF START-UPS/SMES
                        TABLE 393 MARKET: DETAILED LIST OF KEY START-UPS/SMES
                        TABLE 394 MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES
     13.8 COMPETITIVE SCENARIO AND TRENDS 
             13.8.1 PRODUCT LAUNCHES
                        TABLE 395 CELL ISOLATION MARKET: PRODUCT LAUNCHES, JANUARY 2020–MAY 2023
             13.8.2 DEALS
                        TABLE 396 MARKET: DEALS, JANUARY 2020–MAY 2023
             13.8.3 OTHER DEVELOPMENTS
                        TABLE 397 MARKET: OTHER DEVELOPMENTS, JANUARY 2020–MAY 2023
 
14 COMPANY PROFILES (Page No. - 248)
     14.1 KEY PLAYERS 
(Business Overview, Products offered, Recent Developments, MnM View)*
             14.1.1 THERMO FISHER SCIENTIFIC, INC.
                        TABLE 398 THERMO FISHER SCIENTIFIC, INC.: COMPANY OVERVIEW
                        FIGURE 35 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022)
             14.1.2 BECTON, DICKINSON AND COMPANY (BD)
                        TABLE 399 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
                        FIGURE 36 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
             14.1.3 DANAHER CORPORATION
                        TABLE 400 DANAHER CORPORATION: COMPANY OVERVIEW
                        FIGURE 37 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
             14.1.4 MERCK KGAA
                        TABLE 401 MERCK KGAA: COMPANY OVERVIEW
                        FIGURE 38 MERCK KGAA: COMPANY SNAPSHOT (2022)
             14.1.5 TERUMO CORPORATION
                        TABLE 402 TERUMO CORPORATION: COMPANY OVERVIEW
                        FIGURE 39 TERUMO CORPORATION: COMPANY SNAPSHOT (2022)
             14.1.6 AGILENT TECHNOLOGIES, INC.
                        TABLE 403 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
                        FIGURE 40 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
             14.1.7 BIO-RAD LABORATORIES, INC.
                        TABLE 404 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
                        FIGURE 41 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
             14.1.8 CORNING INCORPORATED
                        TABLE 405 CORNING INCORPORATED: COMPANY OVERVIEW
                        FIGURE 42 CORNING INCORPORATED: COMPANY SNAPSHOT (2022)
             14.1.9 F. HOFFMANN-LA ROCHE LTD.
                        TABLE 406 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
                        FIGURE 43 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
             14.1.10 ALFA LAVAL
                        TABLE 407 ALFA LAVAL: COMPANY OVERVIEW
                        FIGURE 44 ALFA LAVAL: COMPANY SNAPSHOT (2022)
             14.1.11 MILTENYI BIOTEC
                        TABLE 408 MILTENYI BIOTEC: COMPANY OVERVIEW
             14.1.12 SARTORIUS AG
                        TABLE 409 SARTORIUS AG: COMPANY OVERVIEW
                        FIGURE 45 SARTORIUS AG: COMPANY SNAPSHOT (2022)
             14.1.13 STEMCELL TECHNOLOGIES
                        TABLE 410 STEMCELL TECHNOLOGIES: COMPANY OVERVIEW
             14.1.14 AKADEUM LIFE SCIENCES
                        TABLE 411 AKADEUM LIFE SCIENCES: COMPANY OVERVIEW
             14.1.15 BIO-TECHNE
                        TABLE 412 BIO-TECHNE: COMPANY OVERVIEW
                        FIGURE 46 BIO-TECHNE: COMPANY SNAPSHOT (2022)
     14.2 OTHER COMPANIES 
             14.2.1 TAKARA BIO INC.
             14.2.2 QIAGEN
             14.2.3 LONZA GROUP
             14.2.4 PERKINELMER INC. (BIOLEGEND, INC.)
             14.2.5 PROMEGA CORPORATION
             14.2.6 PROTEINTECH GROUP, INC.
             14.2.7 PLURISELECT LIFE SCIENCE UG (HAFTUNGSBESCHRÄNKT) & CO. KG
             14.2.8 INVENT BIOTECHNOLOGIES, INC.
             14.2.9 MICAREO INC.
             14.2.10 MAGBIO GENOMICS
 
*Details on Business Overview, Products offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
 
15 APPENDIX (Page No. - 299)
     15.1 DISCUSSION GUIDE 
     15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     15.3 CUSTOMIZATION OPTIONS 
     15.4 RELATED REPORTS 
     15.5 AUTHOR DETAILS 

Research for this study involved estimating the current size and forecast of the cell isolation market through secondary and primary research. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent markets. The next step was to validate these findings & assumptions with industry experts across the value chain through primary research. The market estimates arrived by top-down and other approaches were triangulated to estimate the market size of segments and subsegments. Market growth forecasts were derived by developing assumptions based on revenue growth & key developments from major market players, industry drivers and inputs from demand and supply side experts.

Secondary Research

The secondary sources referred to for this research study include publications from government and private sources such as Centers for Disease Control and Prevention (CDC), Stem Cell Society Singapore (SCSS), International Society for Advancement of Cytometry (ISAC), American Filtration and Separations Society (AFS), National Center for Biotechnology Information (NCBI), National Institutes of Health (NIH), World Health Organization (WHO), Company Websites, Annual Reports, SEC Filings, Press Releases, Investor Presentations, Journals, Expert Interviews, and MarketsandMarkets Analysis. Secondary data was collected and analyzed to arrive at the overall size of the global cell isolation market, which was then validated by primary research.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Cell Isolation/Cell Separation Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Top-down approach was used to estimate and validate the total size of the cell isolation market. This method was also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive secondary research
  • The revenues generated from the cell isolation products business of leading players have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Cell isolation/cell separation is the process of isolating specific cells from given samples. It is a powerful tool in biological research that enables an individual cell type to be isolated from heterogeneous cell populations without contamination from another cell type. This process is widely used for biomolecule isolation for production of vaccines, drugs, antibodies, enzymes, proteins, and other biotechnology products.

Key Stakeholders

  • Cell isolation product manufacturers
  • Cell biology associations
  • Research & consulting firms
  • Distributors of cell isolation products
  • Contract manufacturers of global cell isolation products
  • Biotechnology, biopharmaceutical, and pharmaceutical companies
  • Healthcare institutes (hospitals, medical schools, diagnostic centers, cell banks, and outpatient clinics)
  • Research institutes and clinical research organizations (CROs)
  • Venture capitalists
  • Insurance providers
  • Government bodies

Report Objectives

  • To define, describe, and forecast the global cell isolation market based on the product, cell type, cell source, technique, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, and opportunities)
  • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
  • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as acquisitions, expansions, agreements, collaborations, and R&D activities in the market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Geographic Analysis

  • Further breakdown of the Rest of Europe cell isolation market into respective countries
  • Further breakdown of the Rest of Asia Pacific cell isolation market into respective countries

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Company Information

  • An additional five company profiles
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
BT 2757
Published ON
May, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Cell Isolation Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback